Developing a booster intervention to supplement complex interventions, focusing on interventions for chronic low back pain. A feasibility study.

Associate Professor James McAuley0 个研究点目标入组 50 人开始时间: 2019年5月20日最近更新: 2019年7月15日

适应症

试验速览

暂无简介。

•(As per RESOLVE trial)
•Participation in the RESOLVE trial
•Primary complaint of pain in the area between the 12th rib and buttock crease with or without accompanying leg pain
•Low back pain of at least 12 weeks duration
•Mean pain intensity Numerical Rating Scale (NRS) greater than or equal to 3/10 in the past week
•Sufficient fluency in English language to understand and respond to English language questionnaires and to engage with the intervention
•Partner (friend or spouse) who is able to assist with home component of intervention
•Internet access
•Age 18-70, inclusive

•(As per RESOLVE trial)
•Known or suspected serious spinal pathology (fracture; malignant, inflammatory or infective diseases of the spine; cauda equina syndrome or widespread neurological disorder)
•Suspected or confirmed pregnancy or less than six months post-partum
•Nerve root compromise (any two of altered strength, reflex or sensation for the same nerve root)
•Spinal surgery less than twelve months previously
•Scheduled for major surgery during the treatment or follow-up period
•Any of the contraindications to exercise listed in the American College of Sports Medicine guidelines
•Uncontrolled mental health condition (eg, schizophrenia, bipolar disorder, major depressive disorder) that precludes successful participation
•Any of the contra-indications to electrotherapeutic agents

发起方

Associate Professor James McAuley